UID:
almafu_9958103804102883
Format:
1 online resource (188 p.)
ISBN:
1-280-60665-7
,
9786610606658
,
92-64-01404-7
Content:
This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries - Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain. The report summarises the results of in-depth studies, providing a comparative analysis of participating countries' performance in science and innovation in biopharmaceuticals. It highlights specific characteristics of the national biopharmaceutical innovation systems in terms of their international openness and the specific role of demand-side factors in the innovation process. Major systemic failures affecting the functioning of the biopharmaceutical innovation systems are identified. Based on rich evidence, the report draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.
Note:
"The pharmaceutical biotechnology case study comprised eight participating countries: Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain"--Foreword.
,
Structure, Dynamics and Performance in National Biopharmaceutical Innovation Systems -- Systemic Imperfections in Biopharmaceutical Innovation Systems -- Policy Implications -- Executive Summary -- Introduction -- Summary of Country Studies -- Comparison of Performance in National Biopharmaceutical Innovation Sy -- Openness of the Biopharmaceutical Innovation System.
,
English
Additional Edition:
ISBN 92-64-01403-9
Language:
English
